[In hospital and mid-term outcome of patients with NIR stent implantation: multicenter ESPORT-NIR registry].
OBJECTIVE
Despite improvements in the results and techniques of catheter-based revascularization, few studies have evaluated the clinical results of the application of new stent designs. We describe the in-hospital and mid-term outcome of patients undergoing a stent NIR implantation.


METHODS
At least 1 Stent NIR was implanted in 1.004 patients (1.136 lesions) recruited from 50 centers in an international, multicenter, prospective, registry (Spain and Portugal NIR stent registry). Inclusion criteria were objective coronary ischemia related to a severe de novo lesion or first restenosis in native vessels with a reference diameter >= 2.75 mm. The primary end-point was the incidence of major adverse cardiac events within the first 7 months of follow-up.


RESULTS
The mean age of the patients was 60 years and 82% were male. Angioplasty was indicated due to unstable angina in 61% of the cases. Stent implantation was successfully achieved in 99.6%. Clinical success (angiographic success without in-hospital major events) was achieved in 98.6% of patients. The rate of angiographic restenosis (> 50% stenosis narrowing) was 16% (CI 95%; 11.7-21.2). The accumulated major cardiac adverse event rate at seven months of follow-up was 8.7%: death (0.9%), acute myocardial infarction (1.2%) and target lesion revascularization (6.6%).


CONCLUSIONS
In the wide setting of the population included in the ESPORT-NIR registry, stent NIR implantation was a highly effective therapy with a good mid-term clinical and angiographic outcome.
Iñiguez
A
A
Unidad Hemodinámica-Cardiología Intervencionista. Fundación Jiménez Díaz. Madrid. iniguez@arrakis.es
García
E
E
Seabra
R
R
Bordes
P
P
Bethencourt
A
A
Rigla
J
J
D000789:Angina, Unstable / Q000601:surgery; D003327:Coronary Disease / Q000601:surgery*; D005260:Female; D006083:Graft Occlusion, Vascular / Q000453:epidemiology; D006801:Humans; D008297:Male; D011174:Portugal; D011446:Prospective Studies; D012042:Registries; D013030:Spain; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome